Dendritic Cell Targeting Peptide-Based Nanovaccines for Enhanced Cancer Immunotherapy.

导出 LinkOut

翻译打印收藏纠错

作者： Yating,Liu ^[1] ; Lintong,Yao ^[1] ; Wenpeng,Cao ^[1] ; Yajing,Liu ^[1] ; Wenjie,Zhai ^[1] ; Yahong,Wu ^[1] ; Binglin,Wang ^[1] ; Shanshan,Gou ^[1] ; Yaping,Qin ^[1] ; Yuanming,Qi ^[1] ; Zhenzhen,Chen ^[2] ; Yanfeng,Gao ^[1]

作者单位： School of Life Sciences, Zhengzhou University, Zhengzhou 450001, China. ^[1] Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou, Henan 450001, China. ^[2] School of Pharmaceutical Sciences (Shenzhen), Sun Yat-Sen University, Shenzhen 518107, China. ^[3]

关键词 cancer immunotherapy dendritic cell mesoporous silica nanoparticle peptide vaccine

DOI 10.1021/acsabm.8b00811

PMID 35021373

发布时间 2022-01-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

ACS applied bio materials

2019年2卷3期

1241-1254页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Dendritic Cell Targeting Peptide-Based Nanovaccines for Enhanced Cancer Immunotherapy.

ACS applied bio materials

相似文献

ACS applied bio materials

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Dendritic Cell Targeting Peptide-Based Nanovaccines for Enhanced Cancer Immunotherapy.

ACS applied bio materials

相似文献

ACS applied bio materials

相关期刊

检索历史清除